A股异动丨盟科药业跌逾6% 多名股东拟合计减持不超6%公司股份

Group 1 - The core point of the article is that Mengke Pharmaceutical (688373.SH) has seen a decline of 6.27%, currently trading at 7.33 yuan, with a market capitalization of 4.8 billion yuan [1] - Major shareholders BestIdea, JSR, and GPTMT plan to reduce their holdings by up to 39.3363 million shares, which represents no more than 6% of the company's total share capital [1] - The reduction in shareholding is primarily driven by the shareholders' own funding needs [1]